EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis–Associated Interstitial Lung Disease

Cristina M Padilla iD, Robert Lafyatis, Kevin F Gibson, Christina Morse, Eleanor Valenzi iD, Xiaoping Chen, Xiaoyun Li, Yanwu Zhao, Yongseok Park, Dana Ascherman iD, Jonathan Minden, Robyn Domsic iD und 2 weitere

Arthritis Care & Research · 2026

DOI: 10.1002/acr.25619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Care & Research, 2026. Verfasst von Cristina M Padilla und 13 weiteren Autor:innen. Beteiligte Einrichtung: University of Pittsburgh, Pittsburgh, Pennsylvania. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Scleroderma, Systemic, rhoB GTP-Binding Protein, Monocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, Mitsubishi Tanabe Pharma Corporation, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

A leading cause of death among patients with scleroderma (SSc), interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool. We aimed to identify gene signatures that would predict progressive ILD.

Methods

We compared previously identified serum biomarkers, bulk peripheral blood mononuclear cell (PBMC) RNA gene expression (39 patients with progressive SSc‐ILD and 43 patients with stable SSc‐ILD), and single‐cell RNA gene expression of PBMC (13 patients with progressive SSc‐ILD, 14 patients with stable SSc‐ILD, and 6 control participants).

Results

In previous studies, male sex, Krebs von den Lungen 6 levels, and C‐reactive protein levels were predictors of progressive disease in patients. Monocyte expression of lipoxygenase homology domains 1 (LOXHD1) and Ras homolog gene family, member B (RHOB) strongly predicted progression, suggesting a key role in immune dysregulation. LOXHD1 and related genes were enriched in inflammatory gene networks, which may support monocyte‐associated inflammation in patients. RHOB was consistently up‐regulated in both CD14+ and CD16+ monocytes across single‐cell and bulk RNA data, underscoring robust association with progressive disease. In contrast, ataxin‐2‐like (ATXN2L) protein was down‐regulated in patients with progressive disease, suggesting dysregulation of cellular stress responses. Additionally, S100 calcium‐binding protein A12 (S100A12), chitinase‐3‐like protein 1 (CHI3L1), and matrix metalloproteinase‐9 (MMP9), previously linked to tissue remodeling, were again associated with progression in bulk RNA sequencing and previous microarray studies, reinforcing their role in fibrosis.

Conclusion

With several potential biomarkers of progressive disease in patients, the next step includes validation in larger, multicenter cohorts for use in clinical decision‐making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialScleroderma, SystemicrhoB GTP-Binding ProteinMonocytesScavenger Receptors, Class EHumansMaleFemaleMiddle AgedDisease ProgressionAgedBiomarkersPredictive Value of TestsAdult

Substanzen

rhoB GTP-Binding ProteinScavenger Receptors, Class EBiomarkers

Autor:innen und Institutionen

  • University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Carnegie Mellon University, Pittsburgh, Pennsylvania.

ORCID-Profile: Cristina M Padilla, Eleanor Valenzi, Dana Ascherman, Robyn Domsic

Förderung

  • NIAMS NIH HHS
  • Mitsubishi Tanabe Pharma Corporation
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Padilla, C. M., Lafyatis, R., Gibson, K. F., Morse, C., Valenzi, E., Chen, X., Li, X., Zhao, Y., Park, Y., Ascherman, D., Minden, J., Domsic, R., Zhang, Y., & Kass, D. J. (2026). Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis–Associated Interstitial Lung Disease. Arthritis Care & Research. https://doi.org/10.1002/acr.25619

Vancouver

Padilla CM, Lafyatis R, Gibson KF, Morse C, Valenzi E, Chen X, et al. Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis–Associated Interstitial Lung Disease. Arthritis Care & Research. 2026. doi:10.1002/acr.25619

BibTeX
@article{Padilla2026,
  author = {Padilla, Cristina M and Lafyatis, Robert and Gibson, Kevin F and Morse, Christina and Valenzi, Eleanor and Chen, Xiaoping and Li, Xiaoyun and Zhao, Yanwu and Park, Yongseok and Ascherman, Dana and Minden, Jonathan and Domsic, Robyn and Zhang, Yingze and Kass, Daniel J},
  title = {Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis–Associated Interstitial Lung Disease},
  journal = {Arthritis Care & Research},
  year = {2026},
  doi = {10.1002/acr.25619}
}
Kostenlos starten →